Ajanta Pharma

Ajanta Pharma Ltd Nine Monthly Results

NSEBSE

₹2,880.7

(0.55%)

Jan 20, 2025|03:31:16 PM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
Gross Sales	3,154.63	2,860.8	2,470.7	2,132.85	1,905.91
Excise Duty	0	0	0	0	0
Net Sales	3,154.63	2,860.8	2,470.7	2,132.85	1,905.91
Other Operating Income	0	0	0	0	0
Other Income	66.67	108.04	86.2	23.45	35.5
Total Income	3,221.3	2,968.84	2,556.9	2,156.3	1,941.41
Total Expenditure	2,278.58	2,273.15	1,748.09	1,393.7	1,375.33
PBIDT	942.72	695.69	808.81	762.6	566.08
Interest	5.68	4.71	2.86	5.71	8.29
PBDT	937.04	690.98	805.95	756.89	557.79
Depreciation	101.15	97.78	94.14	85.49	69.68
Minority Interest Before NP	0	0	0	0	0
Tax	248.95	140.25	156.06	178.04	136.82
Deferred Tax	-26.51	-12.78	-5.72	-1.25	12.75
Reported Profit After Tax	613.45	465.73	561.47	494.61	338.54
Minority Interest After NP	0	0	0	0	0
Net Profit after Minority Interest	613.45	465.73	561.47	494.61	338.54
Extra-ordinary Items	0	0	0	0	-0.98
Adjusted Profit After Extra-ordinary item	613.45	465.73	561.47	494.61	339.52
EPS (Unit Curr.)	48.72	36.35	64.89	57.16	38.8
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	2,550	0	475	0	650
Equity	25.27	25.71	17.39	17.39	17.54
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	29.88	24.31	32.73	35.75	29.7
PBDTM(%)	29.7	24.15	32.62	35.48	29.26
PATM(%)	19.44	16.27	22.72	23.19	17.76

No Record Found

Invest wise with Expert advice